A comparative study on the three calculation methods for reproduction numbers of COVID-19

被引:2
作者
Abudunaibi, Buasiyamu [1 ]
Liu, Weikang [1 ]
Guo, Zhinan [2 ]
Zhao, Zeyu [1 ,3 ]
Rui, Jia [1 ,3 ]
Song, Wentao [1 ]
Wang, Yao [1 ]
Chen, Qiuping [3 ]
Frutos, Roger [3 ]
Su, Chenghao [4 ]
Chen, Tianmu [1 ]
机构
[1] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China
[2] Xiamen Ctr Dis Control & Prevent, Xiamen, Fujian, Peoples R China
[3] Univ Montpellier, Cirad, UMR 17, Intertryp, Montpellier, France
[4] Fudan Univ, Zhongshan Hosp, Xiamen Branch, Xiamen, Fujian, Peoples R China
基金
比尔及梅琳达.盖茨基金会;
关键词
COVID-19; reproduction number (R); definition methods; next generation matrix; serial interval (SI); CHINA; TRANSMISSION; EPIDEMIC;
D O I
10.3389/fmed.2022.1079842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThis study uses four COVID-19 outbreaks as examples to calculate and compare merits and demerits, as well as applicational scenarios, of three methods for calculating reproduction numbers. MethodThe epidemiological characteristics of the COVID-19 outbreaks are described. Through the definition method, the next-generation matrix-based method, and the epidemic curve and serial interval (SI)-based method, corresponding reproduction numbers were obtained and compared. ResultsReproduction numbers (R-eff), obtained by the definition method of the four regions, are 1.20, 1.14, 1.66, and 1.12. Through the next generation matrix method, in region H R-eff = 4.30, 0.44; region P R-eff = 6.5, 1.39, 0; region X R-eff = 6.82, 1.39, 0; and region Z R-eff = 2.99, 0.65. Time-varying reproduction numbers (R-t), which are attained by SI of onset dates, are decreasing with time. Region H reached its highest R-t = 2.8 on July 29 and decreased to R-t < 1 after August 4; region P reached its highest R-t = 5.8 on September 9 and dropped to R-t < 1 by September 14; region X had a fluctuation in the R-t and R-t < 1 after September 22; R-t in region Z reached a maximum of 1.8 on September 15 and decreased continuously to R-t < 1 on September 19. ConclusionThe reproduction number obtained by the definition method is optimal in the early stage of epidemics with a small number of cases that have clear transmission chains to predict the trend of epidemics accurately. The effective reproduction number R-eff, calculated by the next generation matrix, could assess the scale of the epidemic and be used to evaluate the effectiveness of prevention and control measures used in epidemics with a large number of cases. Time-varying reproduction number R-t, obtained via epidemic curve and SI, can give a clear picture of the change in transmissibility over time, but the conditions of use are more rigorous, requiring a greater sample size and clear transmission chains to perform the calculation. The rational use of the three methods for reproduction numbers plays a role in the further study of the transmissibility of COVID-19.
引用
收藏
页数:14
相关论文
共 29 条
[1]   Serial interval and incubation period of COVID-19: a systematic review and meta-analysis [J].
Alene, Muluneh ;
Yismaw, Leltework ;
Assemie, Moges Agazhe ;
Ketema, Daniel Bekele ;
Gietaneh, Wodaje ;
Birhan, Tilahun Yemanu .
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[3]   Presumed Asymptomatic Carrier Transmission of COVID-19 [J].
Bai, Yan ;
Yao, Lingsheng ;
Wei, Tao ;
Tian, Fei ;
Jin, Dong-Yan ;
Chen, Lijuan ;
Wang, Meiyun .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14) :1406-1407
[4]   A mechanistic and data-driven reconstruction of the time-varying reproduction number: Application to the COVID-19 epidemic [J].
Cazelles, Bernard ;
Champagne, Clara ;
Nguyen-Van-Yen, Benjamin ;
Comiskey, Catherine ;
Vergu, Elisabeta ;
Roche, Benjamin .
PLOS COMPUTATIONAL BIOLOGY, 2021, 17 (07)
[5]   A mathematical model for simulating the phase-based transmissibility of a novel coronavirus [J].
Chen, Tian-Mu ;
Rui, Jia ;
Wang, Qiu-Peng ;
Zhao, Ze-Yu ;
Cui, Jing-An ;
Yin, Ling .
INFECTIOUS DISEASES OF POVERTY, 2020, 9 (01)
[6]   Nomogram Model for Prediction of SARS-CoV-2 Breakthrough Infection in Fujian: A Case-Control Real-World Study [J].
Chen, Tianbin ;
Zeng, Yongbin ;
Yang, Di ;
Ye, Wenjing ;
Zhang, Jiawei ;
Lin, Caorui ;
Huang, Yihao ;
Ye, Yucheng ;
Li, Jianwen ;
Ou, Qishui ;
Li, Jinming ;
Liu, Can .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
[7]   Impact of interventions on the incidence of natural focal diseases during the outbreak of COVID-19 in Jiangsu Province, China [J].
Cheng, Xiaoqing ;
Hu, Jianli ;
Luo, Li ;
Zhao, Zeyu ;
Zhang, Nan ;
Hannah, Mikah Ngwanguong ;
Rui, Jia ;
Lin, Shengnan ;
Zhu, Yuanzhao ;
Wang, Yao ;
Yang, Meng ;
Xu, Jingwen ;
Liu, Xingchun ;
Yang, Tianlong ;
Liu, Weikang ;
Li, Peihua ;
Deng, Bin ;
Li, Zhuoyang ;
Liu, Chan ;
Huang, Jiefeng ;
Peng, Zhihang ;
Bao, Changjun ;
Chen, Tianmu .
PARASITES & VECTORS, 2021, 14 (01)
[8]   Natural history and cycle threshold values analysis of COVID-19 in Xiamen City, China [J].
Deng, Bin ;
Liu, Weikang ;
Guo, Zhinan ;
Luo, Li ;
Yang, Tianlong ;
Huang, Jiefeng ;
Abudunaibi, Buasiyamu ;
Zhang, Yidun ;
Ouyang, Xue ;
Wang, Demeng ;
Su, Chenghao ;
Chen, Tianmu .
INFECTIOUS DISEASE MODELLING, 2022, 7 (03) :486-497
[9]   Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe [J].
Flaxman, Seth ;
Mishra, Swapnil ;
Gandy, Axel ;
Unwin, H. Juliette T. ;
Mellan, Thomas A. ;
Coupland, Helen ;
Whittaker, Charles ;
Zhu, Harrison ;
Berah, Tresnia ;
Eaton, Jeffrey W. ;
Monod, Melodie ;
Ghani, Azra C. ;
Donnelly, Christl A. ;
Riley, Steven ;
Vollmer, Michaela A. C. ;
Ferguson, Neil M. ;
Okell, Lucy C. ;
Bhatt, Samir .
NATURE, 2020, 584 (7820) :257-+
[10]   Natural history of COVID-19 and therapeutic options [J].
Gautret, Philippe ;
Million, Matthieu ;
Jarrot, Pierre-Andre ;
Camoin-Jau, Laurence ;
Colson, Philippe ;
Fenollar, Florence ;
Leone, Marc ;
La Scola, Bernard ;
Devaux, Christian ;
Gaubert, Jean Yves ;
Mege, Jean-Louis ;
Vitte, Joana ;
Melenotte, Clea ;
Rolain, Jean-Marc ;
Parola, Philippe ;
Lagier, Jean-Christophe ;
Brouqui, Philippe ;
Raoult, Didier .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (12) :1159-1184